47 related articles for article (PubMed ID: 29352692)
21. Correction: Absolute and relative GFR and contrast medium dose/GFR ratio: cornerstones when predicting the risk of acute kidney injury.
Nyman U; Leander P; Liss P; Sterner G; Brismar T
Eur Radiol; 2024 Mar; 34(3):2123-2124. PubMed ID: 37668696
[No Abstract] [Full Text] [Related]
22. Correction to: Absolute and relative GFR and contrast medium dose/GFR ratio: cornerstones when predicting the risk of acute kidney injury.
Nyman U; Leander P; Liss P; Sterner G; Brismar T
Eur Radiol; 2024 May; 34(5):3526. PubMed ID: 37851122
[No Abstract] [Full Text] [Related]
23. C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem.
Zhao Y; Xiao C; Hou J; Wu J; Xiao Y; Zhang B; Sandaradura I; Luo H; Li J; Yan M
Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625314
[TBL] [Abstract][Full Text] [Related]
24. Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients.
Zhao YC; Zou Y; Xiao YW; Wang F; Zhang BK; Xiang DX; Yu F; Luo H; Sandaradura I; Yan M
Infect Dis Ther; 2022 Feb; 11(1):201-216. PubMed ID: 34748194
[TBL] [Abstract][Full Text] [Related]
25. Concordance of estimated glomerular filtration rates using Cockcroft-Gault modification of diet in renal disease, and chronic kidney disease epidemiology in renal transplant recipients.
Ruiz-Esteban P; López V; García-Frías P; Cabello M; González-Molina M; Vozmediano C; Hernandez D
Transplant Proc; 2012 Nov; 44(9):2561-3. PubMed ID: 23146454
[TBL] [Abstract][Full Text] [Related]
26. Renal assessment using CKD-EPI equation is useful as an early predictor of contrast- induced nephropathy in elderly patients with cancer.
Park SY; Lee KW
J Geriatr Oncol; 2017 Jan; 8(1):44-49. PubMed ID: 27491499
[TBL] [Abstract][Full Text] [Related]
27. Glomerular filtration rate (GFR) during and after STEMI: a single-centre, methodological study comparing estimated and measured GFR.
Venetsanos D; Alfredsson J; Segelmark M; Swahn E; Lawesson SS
BMJ Open; 2015 Sep; 5(9):e007835. PubMed ID: 26399570
[TBL] [Abstract][Full Text] [Related]
28. Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level.
Assareh A; Yazdankhah S; Ahmadzadeh A; Yadollahzadeh M; Nasehi N; Haybar H
J Res Med Sci; 2012 Sep; 17(9):859-64. PubMed ID: 23826014
[TBL] [Abstract][Full Text] [Related]
29. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure.
Valente MA; Hillege HL; Navis G; Voors AA; Dunselman PH; van Veldhuisen DJ; Damman K
Eur J Heart Fail; 2014 Jan; 16(1):86-94. PubMed ID: 23901055
[TBL] [Abstract][Full Text] [Related]
30. CKD-EPI versus Cockcroft-Gault formula for predicting contrast-induced nephropathy following percutaneous coronary intervention in patients without significant renal impairment.
Nunes MBG; Filho AC; Alvares VRC; Meneguz-Moreno R; Lamas E; Loures V; Chamié D; Abizaid A
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):25-33. PubMed ID: 29352692
[TBL] [Abstract][Full Text] [Related]
31. Automating and estimating glomerular filtration rate for dosing medications and staging chronic kidney disease.
Trinkley KE; Nikels SM; Page RL; Joy MS
Int J Gen Med; 2014; 7():211-8. PubMed ID: 24833913
[TBL] [Abstract][Full Text] [Related]
32. Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis.
Iliopoulos G; Daoussis D
Rheumatol Int; 2021 Jul; 41(7):1203-1208. PubMed ID: 33844037
[TBL] [Abstract][Full Text] [Related]
33. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Muto S; Matsubara T; Inoue T; Kitamura H; Yamamoto K; Ishii T; Yazawa M; Yamamoto R; Okada N; Mori K; Yamada H; Kuwabara T; Yonezawa A; Fujimaru T; Kawano H; Yokoi H; Doi K; Hoshino J; Yanagita M
Int J Clin Oncol; 2023 Oct; 28(10):1259-1297. PubMed ID: 37382749
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
